- Jharkhand High Court extends RJD president Lalu Prasad's provisional bail till July 3
- Missing county has been blessing in disguise: Kohli
- ISJK chief among four militants killed in Kashmir, cop and civilian also dead
- ED moves special court to declare Vijay Mallya fugitive offender
- New Zealand prime minister gives birth to healthy baby girl
HEALTH & FITNESS
Apollo Hospitals ties up with RMS Regrow for cell-based therapy
Apollo Hospitals has partnered with Mumbai-based Regenerative Medical Services (RMS) Regrow to offer a safe and cost-effective cell therapy for cartilage and bone problems for the first time in India.
The partnership will make the cell-based treatment available across all 40 centres of Apollo Hospitals, including Apollo Spectra Hospitals and Apollo clinics in India, the hospital chain said at an event here on Monday.
RMS Regrow, the first "Make in India" company in cell therapy technology, has two treatments: Chondron ACI for knees or cartilage problems and Ossron Autologous Osteoblast Implantation (ABI) for hip joints.
"Nearly 65-70 per cent of people above the age of 40 experience joint problems. The cell therapy may help postpone the need for a replacement surgery and with proper rehabilitation it will also enable a patient to resume normal routine in nearly three months," Prathap C Reddy, Founder-Chairman of Apollo Hospitals told the media.
With the cell-therapy technique, damage to the cartilage can be repaired after the new cultured cartilage is put back into one's knees.
However, for individuals at an advanced stage of osteoarthritis, replacement surgeries will be the best mode of treatment as their cartilages may not be able to regrow.
"Both Ossron and Chondron are efficient in treating a young arthritic knee with sports injuries, accidents and can is an alternative treatment to hip replacements or knee replacements," said Satyen Sanghavi, Chief Scientific Officer at RMS Regrow.
"In the future, the cell therapy-based treatment can also be extended to lengthening of limbs or bones or for maxillofacial defects (defects of the head and neck)," he added.
The company also received a market authorisation approval from the Drug Controller General of India (DGCI) in April this year.
Further, the treatment cost "in India, will be Rs 3.5-4 lakh per patient, which is less than 10 per cent of the cost abroad and will be available in all our hospitals in six months," Reddy said.
- Bisexuals more prone to heart disease risk: Study 22 Jun 2018 | IANS
- Robotic surgery as effective as open surgery for bladder cancer: Study 22 Jun 2018 | IANS
- Drug to stop cancer from spreading developed 22 Jun 2018 | IANS
- Mindful movement may lower stress, anxiety 22 Jun 2018 | IANS
- 4 cups of coffee daily may boost heart functions in elderly 22 Jun 2018 | IANS
- Overweight in middle age linked to low breast cancer risk 22 Jun 2018 | IANS
- New treatment facility for hazardous industrial waste in Delhi 21 Jun 2018 | IANS
- Packet tea consumption rising in India: Study 21 Jun 2018 | IANS
- Weight loss may reverse effects of heart rhythm disorder 21 Jun 2018 | IANS
- Common white pigment linked to diabetes: study 21 Jun 2018 | PTI
Sunday EditionView All
17 Jun 2018 | VR Jayaraj | Kochi
In a swift move intended at stemming the protests brewing in the State police force against certain top officials’ ‘feudalistic’ practice of persecuting policemen and camp followers by using them as house servants, the Kerala Government on Saturday removed ADGP Sudesh Kumar, whose daughter was the other day booked for assaulting and verbally abusing his official police driver, from the position of head of the Armed Police Battalion. The action against...
STATE EDITIONSView All
23 Jun 2018 | PNS | Kochi
MCD still waiting for HC order on encroachment Dehradun: Days after the High Court ordered the officials to remove encroachment from different areas of Dehradun like markets, streets and footpaths in four weeks, the officials concerned said on Friday that they were still waiting for the order to come. They, however, assured that they would execute the order once they get a copy and read it thoroughly...